4Iijima H, Takahashi I, Kiyono H. Mucosal immune network in the gut for the control of infectious diseases [J]. Rev Med Virol, 2001, 11(2): 117-133.
5Briskin M, Winsor HD, Shyjan A, et al. Human mucosal addressin cell adhesion molecule is preferentially expressed in intestinal tract and associated lymphoid tissue [J]. Am J Pathol,1997, 151(7): 97-110.
6Chardes T, Bout D. Mucosal immune response in toxoplasmosis[J]. Res Immunol, 1993, 144(1): 57-60.
7Debard N, Buzoni-Gatel D, Bout D. Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebal cyst after oral infection[J]. Infect Immun, 1996, 64 (6): 2158-2166.
8Velge-Roussel F, Marcelo P, Bout DT, et al. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments [J]. Infect Immun, 2000, 68 (2): 969-972.
9Bonenfant C, Dimier-Poisson I, Velge-Roussel F, et al. Intranasal I mmunization with SAG1 and nontoxic mutant heatlabile enterotoxins protects mice against Toxoplasma gondii[J]. Infect Immun, 2001, 69(4): 1605-1612.
10Gazzinelli R, Xu Y, Hieny S, et al. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii [J]. J Immunol, 1992, 149(1): 175-180.
